AU2017336916A1 - Compositions and methods for the treatment of orthopedic ailments - Google Patents

Compositions and methods for the treatment of orthopedic ailments Download PDF

Info

Publication number
AU2017336916A1
AU2017336916A1 AU2017336916A AU2017336916A AU2017336916A1 AU 2017336916 A1 AU2017336916 A1 AU 2017336916A1 AU 2017336916 A AU2017336916 A AU 2017336916A AU 2017336916 A AU2017336916 A AU 2017336916A AU 2017336916 A1 AU2017336916 A1 AU 2017336916A1
Authority
AU
Australia
Prior art keywords
ginger
arginine
composition
citrulline
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017336916A
Other languages
English (en)
Inventor
Jacob Rajfer
Rebecca RAJFER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
K L R M LLC
Original Assignee
K L R M LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by K L R M LLC filed Critical K L R M LLC
Publication of AU2017336916A1 publication Critical patent/AU2017336916A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2017336916A 2016-09-29 2017-09-29 Compositions and methods for the treatment of orthopedic ailments Abandoned AU2017336916A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662401629P 2016-09-29 2016-09-29
US62/401,629 2016-09-29
US201762511601P 2017-05-26 2017-05-26
US62/511,601 2017-05-26
PCT/US2017/054284 WO2018064469A1 (en) 2016-09-29 2017-09-29 Compositions and methods for the treatment of orthopedic ailments

Publications (1)

Publication Number Publication Date
AU2017336916A1 true AU2017336916A1 (en) 2019-04-18

Family

ID=61760145

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2017336916A Abandoned AU2017336916A1 (en) 2016-09-29 2017-09-29 Compositions and methods for the treatment of orthopedic ailments

Country Status (9)

Country Link
US (3) US10426812B2 (OSRAM)
EP (1) EP3518951B1 (OSRAM)
JP (1) JP7075136B2 (OSRAM)
KR (1) KR102491748B1 (OSRAM)
CN (1) CN110087664B (OSRAM)
AU (1) AU2017336916A1 (OSRAM)
ES (1) ES2971281T3 (OSRAM)
IL (1) IL265571B (OSRAM)
WO (1) WO2018064469A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3518951B1 (en) * 2016-09-29 2024-01-10 K.L.R.M., Llc Compositions for use in the treatment of osteoporis and bone fractures
US20200246414A1 (en) * 2019-02-06 2020-08-06 K.L.R.M., Llc Compositions and methods for the treatment of constipation and other ailments of the gastrointestinal system
CN112791171A (zh) * 2019-11-13 2021-05-14 内蒙古伊利实业集团股份有限公司 姜或其提取物用于防治骨质疏松的用途
CN119818501A (zh) * 2025-01-14 2025-04-15 北京大学口腔医学院 西地那非的新用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000191542A (ja) * 1998-12-25 2000-07-11 Lion Corp 骨粗鬆症予防、治療剤
US6210701B1 (en) 1999-04-30 2001-04-03 Healthcomm International, Inc. Medical food for treating inflammation-related diseases
US7163958B2 (en) 2002-07-03 2007-01-16 Nitromed Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
US20040097467A1 (en) * 2002-08-22 2004-05-20 Vijaya Juturu Arginine silicate inositol complex and use thereof
US20070243132A1 (en) * 2005-12-22 2007-10-18 Apollo Life Sciences Limited Transdermal delivery of pharmaceutical agents
US20120093950A1 (en) * 2010-10-19 2012-04-19 Klrm, Llc Compositions and methods for treating, inhibiting the onset, and slowing the progression of erectile dysfunction including naturally occuring age related erectile dysfunction
US20120121740A1 (en) * 2010-10-19 2012-05-17 K.L.R.M., Llc Compositions and methods for treating, inhibiting the onset, and slowing the progression of erectile dysfunction including naturally occurring age related erectile dysfunction
WO2016141331A1 (en) * 2015-03-04 2016-09-09 K.L.R.M., Llc Methods and compositions for extending the efficacy of phosphodiesterase inhibitors for treating erectile dysfunction
EP3518951B1 (en) * 2016-09-29 2024-01-10 K.L.R.M., Llc Compositions for use in the treatment of osteoporis and bone fractures

Also Published As

Publication number Publication date
IL265571B (en) 2022-03-01
EP3518951A1 (en) 2019-08-07
CN110087664B (zh) 2022-11-01
US10426812B2 (en) 2019-10-01
US20180104300A1 (en) 2018-04-19
ES2971281T3 (es) 2024-06-04
EP3518951A4 (en) 2020-05-27
JP2019529569A (ja) 2019-10-17
EP3518951B1 (en) 2024-01-10
WO2018064469A1 (en) 2018-04-05
US20200215146A1 (en) 2020-07-09
EP3518951C0 (en) 2024-01-10
KR20190061045A (ko) 2019-06-04
IL265571A (en) 2019-05-30
CN110087664A (zh) 2019-08-02
US20190381124A1 (en) 2019-12-19
JP7075136B2 (ja) 2022-05-25
US10792324B2 (en) 2020-10-06
KR102491748B1 (ko) 2023-01-25

Similar Documents

Publication Publication Date Title
US10792324B2 (en) Compositions and methods for the treatment of orthopedic ailments
JP2022037132A (ja) 筋萎縮性側索硬化症患者の下位集団の治療のためのマシチニブの使用
Aydoğan et al. The effect of vitamin D and bisphosphonate on fracture healing: An experimental study
US9827273B2 (en) Preparation and method for the prophylaxis and treatment of atypical osteoporosis
Rajfer et al. Enhancement of fracture healing in the rat, modulated by compounds that stimulate inducible nitric oxide synthase: acceleration of fracture healing via inducible nitric oxide synthase
EP2429537B1 (en) A fertilized, incubated avian egg or extract for the treatment of stress
BR112017007364B1 (pt) Composições farmacêuticas e usos das mesmas para o tratamento ou prevenção de deficiências de vitaminas e minerais em pacientes submetidos à cirurgia de bypass gástrico
KR102376603B1 (ko) 제니스테인 포스페이트 콘쥬게이트의 조성물의, 골량의 감소와 관련된 질환의 치료 또는 예방을 위한 사용 및 골 구조 및 골의 생체역학 강도를 개선하기 위한 사용
CN104587470A (zh) 一种促进骨质疏松性骨折术后骨愈合的药物组合物及其应用
HK40010195A (en) Compositions and methods for the treatment of orthopedic ailments
HK40010195B (en) Compositions and methods for the treatment of orthopedic ailments
EP4392053A1 (en) Compositions and methods for treatment of bone-related disease or disorder
DOWNEY Thwart POST-MEAL Bloating and Indigestion
Tatara et al. 7. Novel and current approaches to dietary and non-dietary bone metabolism regulation
Agrawal et al. Topical Nitroglycerin: A New and Safe Treatment Option for Osteoporosis
KR20220064039A (ko) 척수 손상 예방 또는 치료용 조성물
US20180193312A1 (en) Nutraceutical composition and dosing regimen
Kumar Therapeutic Applications of Chondroitin Sulphate, Collagen and Rosehip Extract in the Musculoskeletal System
Irazoqui et al. 1alpha, 25 (OH) 2-vitamin D3 effects in cellular cycle of Rhabdomyosarcoma cells
US20140309310A1 (en) Pharmaceutical Composition for Preventing or Treating Disease with Bone Mass Loss Comprising Diaminodiphenylsulfone or Pharmaceutically Acceptable Salt Thereof
Vargas-Schaffer Drugs able to prevent chronic pain
KR20160004697A (ko) 골다공증 예방 및 치료용 조성물

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application